Recent News

By Category: Research

Experts disagree over H5N1 as HHS select agent – Vaccine News Daily (blog)

Vaccine News Daily (blog)Experts disagree over H5N1 as HHS select agentVaccine News Daily (blog)Professional groups and influenza experts are expressing differences on whether H5N1 influenza, also known as highly pathogenic avian influenza, should be classified as a “select agent.” Select agents require special precautions and permissions to be …

Penn team developing new class of malaria drugs using essential calcium enzyme

(EurekAlert) Calpain, a calcium-regulated enzyme, is essential to a host of cellular processes, but can cause severe problems in its overactivated state. It has been implicated as a factor in muscular dystrophy, AIDS, Alzheimer’s disease, multiple sclerosis, and cancer. As such, finding and exploiting calpain inhibitors is an important area of research. A team from  Read More »

Strange Behavior: New Study Exposes Living Cells to Synthetic Protein

(Science Daily) One approach to understanding components in living organisms is to attempt to create them artificially, using principles of chemistry, engineering and genetics. A suite of powerful techniques — collectively referred to as synthetic biology — have been used to produce self-replicating molecules, artificial pathways in living systems and organisms bearing synthetic genomes. In  Read More »

Scientists sequence genome of pathogen responsible for pneumocystis pneumonia

(EurekAlert) Scientists have sequenced the genome of the fungus Pneumocystis jirovecii, an advancement that could help identify new targets for drugs to treat and prevent Pneumocystis pneumonia, a common and often deadly infection in immunocompromised patients. The study will be published on December 26, 2012 in mBio®, the online open-access journal of the American Society  Read More »

Research reveals new drug target urgently needed for tuberculosis therapy

(EurekAlert) One third of the world is infected with the bacterium that causes tuberculosis (TB), a disease that is increasingly difficult to treat because of wide spread resistance to available drugs. Researchers from the Institute of Pharmacology and Structural Biology (CNRS, Université de Toulouse) in Toulouse (France) have identified a fresh target to develop new  Read More »

« First...102030...118119120121122...130140150...Last »

Also filed under "Research":